Antibacterial effect of Kampo herbal formulation Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang) on Helicobacter pylori infection in mice

被引:43
作者
Yan, XW
Kita, M
Minami, M
Yamamoto, T
Kuriyama, H
Ohno, T
Iwakura, Y
Imanishi, J
机构
[1] Kyoto Prefectural Univ Med, Dept Microbiol, Kamigyo Ku, Kyoto 6028566, Japan
[2] Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 6028566, Japan
[3] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Minato Ku, Tokyo 1088639, Japan
关键词
Helicobacter pylori; Kampo herbal formulation; interferon-gamma;
D O I
10.1111/j.1348-0421.2002.tb02721.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Because Helicobacter pylori (H. pylori) infection is a major cause of gastroduodenal diseases in humans, the eradication of H. pylori using antibiotics is very effective for the treatment of gastroduodenal diseases. However, it has recently been reported that resistance to these antibiotics is developing. In the present study, the antibacterial effect of a Kampo (traditional Japanese medicine) herbal formulation, Hochu-ekki-to (HET; Formula repletionis animalis et supletionis medii), against H. pylori was examined in vitro and in vivo. HET inhibited the growth of antibiotic-resistant strains of H. pylori as well as antibiotic-sensitive strains at a dose of 2.5 mg/ml in vitro. When 1,000 mg/kg of HET was administered orally to C57BL/6 mice for 7 days before or after inoculation with H. pylori, H. pylori in the stomach was significantly reduced in the HET-pre-treatment group compared with the control group. Furthermore, HET in combination with antibiotics completely eradicated the bacteria in mice. The expression of interferon (IFN)-gamma was induced in the gastric mucosa of the mice pre-treated with HET. There were no significant differences between the colonization of H. pylori in the control and HET treatment groups in IFN-gamma gene-deficient mice. These results suggest that the antibacterial effect of HET may be partly due to IFN-gamma induction, and that HET may be clinically useful for treatment of H. pylori infection.
引用
收藏
页码:475 / 482
页数:8
相关论文
共 30 条
[1]   Protection of immunosuppressed mice from lethal Candida infection by oral administration of a Kampo medicine, Hochu-ekki-to [J].
Abe, S ;
Tansho, S ;
Ishibashi, H ;
Akagawa, G ;
Komatsu, Y ;
Yamaguchi, H .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1999, 21 (02) :331-342
[2]   Protective effect of oral administration of a traditional medicine, Juzen-taiho-to, and its components on lethal Candida albicans infection in immunosuppressed mice [J].
Abe, S ;
Tansho, S ;
Ishibashi, H ;
Inagaki, N ;
Komatsu, Y ;
Yamaguchi, H .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1998, 20 (03) :421-431
[3]  
ARAKAWA T, 1990, DRUG INVEST S1, V2, P46
[4]   Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance [J].
Buckley, MJM ;
Xia, HX ;
Hyde, DM ;
Keane, CT ;
OMorain, CA .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (10) :2111-2115
[5]  
CHO J-M, 1991, In Vivo (Attiki), V5, P389
[6]  
DEMIZU S, 1988, CHEM PHARM BULL, V36, P3474
[7]   The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells:: A mechanism for T helper cell type 1-mediated damage [J].
Fan, XJ ;
Crowe, SE ;
Behar, S ;
Gunasena, H ;
Ye, G ;
Haeberle, H ;
Van Houten, N ;
Gourley, WK ;
Ernst, PB ;
Reyes, VE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1659-1669
[8]  
HIZUKA H, 1997, J NEW REMED CLIN, V46, P49
[9]   Treatment of Helicobacter pylori [J].
Hoffman, JS ;
Cave, DR .
CURRENT OPINION IN GASTROENTEROLOGY, 2001, 17 (01) :30-34
[10]  
Hong Tie, 1999, Journal of Traditional Medicines, V16, P58